First Patient Treated 24 Months After Breaking Ground
BLOOMINGTON, Ind. & LOUVAIN-LA-NEUVE, Belgium--(BUSINESS WIRE)-- IBA (Ion Beam Applications S.A.) and ProCure Treatment Centers, Inc., (ProCure) announced today that the CDH Proton Center, A ProCure Center, located outside Chicago, recently delivered proton radiation treatment to its first patients using IBA's Proteus 235 proton delivery system. It took only 24 months to build the facility, install the equipment and treat the first patient, setting a new world record in bringing this important technology to patients who could benefit.
Working together, first in developing a center in Oklahoma City and now in suburban Chicago, IBA and ProCure have reduced the timeline for development and construction of a proton therapy center by a full year.
"This is a momentous occasion that represents a major step forward in the treatment of cancer. We are extremely proud of our partnership with ProCure and the results that it has generated." said Pierre Mottet, Chief Executive Officer of IBA. "IBA has demonstrated its continued leadership in the development of proton centers and just as we did following construction of OKC center, we look forward to making this treatment available to even more patients."
"It takes a real team effort to make this happen," said Hadley Ford, Chief Executive Officer of ProCure. "The IBA crew proved itself at our center in OKC, and consistently exceeded our expectations in Chicago. Their expertise and acumen are of great benefit."
The Chicago center is the second proton therapy installation to use inclined beam technology, which was developed by ProCure and IBA as an alternative to a gantry. The inclined beam can treat approximately 80 percent of the tumors treated with a gantry and fits in a space about half the size of a gantry room, allowing the footprint of the proton centers to be much smaller and making construction less costly. The inclined beam also requires less commissioning time and allows for easier maintenance.
For more visit http://procure.com/media/pressreleases/iba-and-procure-set-record-development-second-proton-therapy-center
CONTACT:
IBA
Sandrine Leriche
VP Corporate Communication
Telephone: +32 10.47.58.90
[email protected]
or
ProCure
Sky Opila
Account Executive
312-558-1770
[email protected]
KEYWORDS: United States Belgium Europe North America Illinois Indiana
INDUSTRY KEYWORDS: Health Hospitals Medical Devices Oncology Radiology Other Health Other Science Science General Health
MEDIA: